- INTRODUCTION
- METHODS
- RESULTS
- DISCUSSION
- REFERENCES
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A101716048
Sungmo Je (Seoul National University College of Medicine) ; Wonjun Bae (Seoul National University College of Medicine) ; Jiyeon Kim (Seoul National University College of Medicine) ; Seung Hyeok Seok ; Eung-Soo Hwang
2015
Korean
475
SCOPUS,KCI등재
학술저널
339-353(15쪽)
0
0
상세조회0
다운로드목차 (Table of Contents)
참고문헌 (Reference)
1 National geographic, "Why a MERS Vaccine Won't Be Easy"
2 Korea Centers for Disease Control and Prevention, "Travelers Health Information"
3 Drosten C, "Transmission of MERS-coronavirus in household contacts" 371 : 828-835, 2014
4 Mou H, "The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies" 87 : 9379-9383, 2013
5 Guo X, "Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus" 145 : 476-484, 2015
6 World Health Organization, "Summary of Current Situation. Literature Update and Risk Assessment"
7 National Institutes of Health, "Study of Ebola survivors opens in Liberia"
8 Korea Tourism Organization, "Statistics of Korean Tourism"
9 Korea Tourism Organization, "Statistics of Korean Departures"
10 Butler D, "South Korean MERS outbreak spotlights lack of research" 522 : 139-140, 2015
1 National geographic, "Why a MERS Vaccine Won't Be Easy"
2 Korea Centers for Disease Control and Prevention, "Travelers Health Information"
3 Drosten C, "Transmission of MERS-coronavirus in household contacts" 371 : 828-835, 2014
4 Mou H, "The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies" 87 : 9379-9383, 2013
5 Guo X, "Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus" 145 : 476-484, 2015
6 World Health Organization, "Summary of Current Situation. Literature Update and Risk Assessment"
7 National Institutes of Health, "Study of Ebola survivors opens in Liberia"
8 Korea Tourism Organization, "Statistics of Korean Tourism"
9 Korea Tourism Organization, "Statistics of Korean Departures"
10 Butler D, "South Korean MERS outbreak spotlights lack of research" 522 : 139-140, 2015
11 Suwantarat N, "Risks to healthcare workers with emerging diseases: lessons from MERS-CoV, Ebola, SARS, and avian flu" 28 : 349-361, 2015
12 Pubmed, "Results by year"
13 Korea Centers for Disease Control and Prevention, "Response Guidelines for MERS"
14 Coleman CM, "Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice" 32 : 3169-3174, 2014
15 Fusco ML, "Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs" 11 : e1005016-, 2015
16 Volz A, "Protective efficacy of recombinant Modified Vaccinia virus Ankara (MVA) delivering Middle East Respiratory Syndrome coronavirus spike glycoprotein" 89 : 8651-8656, 2015
17 Müller MA, "Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, crosssectional, serological study" 15 : 559-564, 2015
18 Kayali G, "Peiris M. A more detailed picture of the epidemiology of Middle East respiratory syndrome coronavirus" 15 : 495-497, 2015
19 Korea Centers for Disease Control and Prevention, "National Reorganization of Disease Control System"
20 Centers for Disease Control and Prevention, "National Notifiable Diseases Surveillance System (NNDSS)"
21 Du L, "Middle East respiratory syndrome: current status and future prospects for vaccine development" 15 : 1647-1651, 2015
22 Al-Tawfiq JA, "Middle East respiratory syndrome coronavirus: transmission and phylogenetic evolution" 22 : 573-579, 2014
23 Reusken CB, "Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study" 13 : 859-866, 2013
24 Haagmans BL, "Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation" 14 : 140-145, 2014
25 World Health Organization, "Middle East respiratory syndrome coronavirus (MERS-CoV): Epicurve of confirmed cases and deaths in Republic of Korea, China, Saudi Arabia and other countries"
26 Reusken CB, "Middle East respiratory syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013" 18 : 20662-, 2013
27 Korea Centers for Disease Control and Prevention, "Middle East Respiratory Syndrome Information"
28 Korea Centers for Disease Control and Prevention, "Middle East Respiratory Syndrome Information"
29 Banik GR, "Middle East Respiratory Syndrome Coronavirus "MERS-CoV": Current Knowledge Gaps" 16 : 197-202, 2015
30 Hemida MG, "Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013" 18 : 20659-, 2013
31 Chu DK, "MERS coronaviruses in dromedary camels, Egypt" 20 : 1049-1053, 2014
32 Zaki AM, "Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia" 367 : 1814-1820, 2012
33 Korea Centers for Disease Control and Prevention, "Infectious disease annual report of 2014"
34 Zhou Y, "Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine" 35 : 131-136, 2015
35 Du L, "Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development" 87 : 9939-9942, 2013
36 Al-Abdallat MM, "Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description" 59 : 1225-1233, 2014
37 Heymann DL, "Global health security: the wider lessons from the west African Ebola virus disease epidemic" 385 : 1884-1901, 2015
38 Reusken CB, "Geographic distribution of MERS coronavirus among dromedary camels, Africa" 20 : 1370-1374, 2014
39 Xie Q, "Genomic sequencing and analysis of the first imported Middle East Respiratory Syndrome Coronavirus (MERS CoV) in China" 58 : 818-820, 2015
40 Lau SK, "Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus" 87 : 8638-8650, 2013
41 Korea Centers for Disease Control and Prevention, "Full disclosure of MERS-hit hospitals"
42 Ministry of Government Legislation, "Disease Prevention and Control Law of 2015" Law 2015
43 Korean Hospital Association, "Compensation for Loss of Hospital in MERS Outbreak"
44 Nakayama Y, "Comparison of Current Regulatory Status for Gene-Based Vaccines in the US, Europe and Japan" 3 : 186-202, 2015
45 Ithete NL, "Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa" 19 : 1697-1699, 2013
46 Muthumani K, "A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates" 7 : 301ra132-, 2015
47 Ministry of Strategy and Finance, "2016 Budget"
The 2013-2015 Ebola outbreak in West Africa
Modified Method of Multilocus Sequence Typing (MLST) for Serotyping in Salmonella Species
Recharacterization of Morphological and Genetic Feature of Getah Virus Isolated from South Korea
학술지 이력
연월일 | 이력구분 | 이력상세 | 등재구분 |
---|---|---|---|
2023 | 평가예정 | 해외DB학술지평가 신청대상 (해외등재 학술지 평가) | |
2020-01-01 | 평가 | 등재학술지 유지 (해외등재 학술지 평가) | |
2010-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2008-01-01 | 평가 | 등재 1차 FAIL (등재유지) | |
2006-07-18 | 학술지명변경 | 외국어명 : 미등록 -> Journal of Bacteriology and Virology | |
2006-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2003-01-01 | 평가 | 등재학술지 선정 (등재후보2차) | |
2002-01-01 | 평가 | 등재후보 1차 PASS (등재후보1차) | |
1998-07-01 | 평가 | 등재후보학술지 선정 (신규평가) |
학술지 인용정보
기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
---|---|---|---|
2016 | 0.23 | 0.23 | 0.2 |
KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
0.19 | 0.18 | 0.358 | 0.03 |